Kumar Neil Insider Trading
Get the latest insider transactions of Kumar Neil. Kumar Neil is Chief Executive Officer in Eidos Therapeutics, Inc. ($EIDX) and CEO and President in BridgeBio Pharma, Inc. ($BBIO) and See Remarks in BridgeBio Pharma, Inc. ($BBIO). Discover the current value of Kumar Neil shares.
Address: C/O EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO 94104CA
Kumar Neil is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
EIDX | Eidos Therapeutics, Inc. | Chief Executive Officer | 24,575,501 | |
BBIO | BridgeBio Pharma, Inc. | CEO and President, See Remarks | 4,697,564 |
Insider Trading Transactions of Kumar Neil
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Feb 18 2021 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Buy | 0.00 | 5,129 | 0 | 4,697,564 |
Feb 18 2021 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 64.98 | 2,139 | 138,992 | 4,695,425 |
Feb 18 2021 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Buy | 62.50 | 16,000 | 1,000,000 | 4,711,425 |
Feb 18 2021 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Option Exercise | 0.00 | 5,129 | 0 | 66,682 |
Feb 12 2021 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Option Exercise | 68.87 | 225,971 | 15,562,623 | 225,971 |
Feb 12 2021 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Option Exercise | 0.00 | 38,306 | 0 | 38,306 |
Nov 18 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Buy | 0.00 | 5,129 | 0 | 4,694,209 |
Nov 18 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 44.33 | 1,774 | 78,641 | 4,692,435 |
Nov 18 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Option Exercise | 0.00 | 5,129 | 0 | 71,811 |
Aug 18 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Buy | 0.00 | 5,129 | 0 | 4,690,854 |
Aug 18 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 28.53 | 1,774 | 50,612 | 4,689,080 |
Aug 18 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Option Exercise | 0.00 | 5,129 | 0 | 76,940 |
Aug 05 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 27.23 | 63,017 | 1,715,808 | 2,102,355 |
Aug 05 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 28.12 | 3,040 | 85,498 | 2,099,315 |
Aug 05 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 26.70 | 7,184 | 191,846 | 2,092,131 |
Aug 05 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 27.36 | 6,759 | 184,914 | 2,085,372 |
Jul 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 30.63 | 50,625 | 1,550,472 | 2,258,217 |
Jul 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 31.67 | 33,700 | 1,067,343 | 2,224,517 |
Jul 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 32.42 | 2,700 | 87,521 | 2,221,817 |
Jul 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 30.22 | 56,445 | 1,706,022 | 2,165,372 |
Jun 10 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 30.01 | 10,600 | 318,125 | 2,308,842 |
Jun 05 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 30.05 | 5,930 | 178,173 | 2,319,442 |
Jun 05 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Option Exercise | 28.86 | 590,551 | 17,043,302 | 590,551 |
Jun 05 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Option Exercise | 0.00 | 82,069 | 0 | 82,069 |
Jun 03 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 29.13 | 71,291 | 2,076,678 | 2,334,081 |
Jun 03 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 29.71 | 8,709 | 258,711 | 2,325,372 |
May 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 30.86 | 44,766 | 1,381,470 | 2,440,206 |
May 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 31.23 | 34,834 | 1,088,012 | 2,405,372 |
Apr 09 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 25.48 | 1,805 | 45,983 | 2,565,372 |
Apr 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 25.09 | 200 | 5,018 | 2,567,277 |
Apr 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 25.10 | 100 | 2,510 | 2,567,177 |
Apr 03 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 25.52 | 27,719 | 707,508 | 2,617,653 |
Apr 03 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 26.38 | 20,040 | 528,623 | 2,597,613 |
Apr 03 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 27.45 | 12,976 | 356,252 | 2,584,637 |
Apr 03 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 28.20 | 1,382 | 38,979 | 2,583,255 |
Apr 03 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 25.04 | 15,778 | 395,103 | 2,567,477 |
Feb 07 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | Sell | 34.87 | 30,893 | 1,077,390 | 2,765,372 |
Feb 05 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Sell | 34.92 | 32,056 | 1,119,309 | 2,853,316 |
Feb 05 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Sell | 35.20 | 2,100 | 73,914 | 2,851,216 |
Feb 05 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Sell | 34.55 | 54,951 | 1,898,387 | 2,796,265 |
Jan 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Sell | 32.55 | 11,091 | 361,042 | 2,994,281 |
Jan 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Sell | 33.41 | 19,793 | 661,342 | 2,974,488 |
Jan 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Sell | 34.19 | 5,077 | 173,560 | 2,969,411 |
Jan 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Sell | 35.17 | 100 | 3,517 | 2,969,311 |
Jan 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Sell | 32.14 | 77,271 | 2,483,706 | 2,892,040 |
Jan 06 2020 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Sell | 32.88 | 6,668 | 219,250 | 2,885,372 |
Jul 08 2019 | EIDX | Eidos Therapeutics, Inc. | Kumar Neil | Chief Executive Offic ... | Buy | 29.90 | 882,353 | 26,382,796 | 24,575,501 |
Jul 08 2019 | EIDX | Eidos Therapeutics, Inc. | Kumar Neil | Chief Executive Offic ... | Buy | 29.90 | 882,353 | 26,382,796 | 24,575,501 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Buy | 0.00 | 323,270 | 0 | 323,270 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Buy | 0.00 | 906,905 | 0 | 1,230,175 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Buy | 0.00 | 1,742,631 | 0 | 2,972,806 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Buy | 0.00 | 2,744,459 | 0 | 5,717,265 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Buy | 0.00 | 1,907,102 | 0 | 7,624,367 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Buy | 0.00 | 400,375 | 0 | 400,375 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Buy | 0.00 | 927,686 | 0 | 927,686 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Option Exercise | 0.00 | 323,270 | 0 | 0 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Option Exercise | 0.00 | 906,905 | 0 | 0 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Option Exercise | 0.00 | 400,375 | 0 | 0 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Option Exercise | 0.00 | 1,742,631 | 0 | 0 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Option Exercise | 0.00 | 927,686 | 0 | 0 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Option Exercise | 0.00 | 2,744,459 | 0 | 0 |
Jul 03 2019 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | See Remarks | Option Exercise | 0.00 | 1,907,102 | 0 | 0 |
May 29 2019 | EIDX | Eidos Therapeutics, Inc. | Kumar Neil | Chief Executive Offic ... | Buy | 25.93 | 1,103,848 | 28,622,779 | 23,693,148 |
Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | Kumar Neil | Chief Executive Offic ... | Buy | 0.00 | 18,826,417 | 0 | 18,826,417 |
Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | Kumar Neil | Chief Executive Offic ... | Sell | 17.00 | 211,762 | 3,599,954 | 18,614,655 |
Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | Kumar Neil | Chief Executive Offic ... | Buy | 17.00 | 1,000,000 | 17,000,000 | 19,614,655 |
Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | Kumar Neil | Chief Executive Offic ... | Option Exercise | 10.83 | 332,262 | 3,599,992 | 0 |
Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | Kumar Neil | Chief Executive Offic ... | Option Exercise | 0.00 | 332,262 | 0 | 2,909,029 |
Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | Kumar Neil | Chief Executive Offic ... | Option Exercise | 0.00 | 2,909,029 | 0 | 0 |
Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | Kumar Neil | Chief Executive Offic ... | Option Exercise | 0.00 | 12,832,123 | 0 | 0 |